Jason Pontin

Jason Pontin is a General Partner at DCVC (Data Collective Venture Capital) in Palo Alto, where he leads communications and originates investments in early-stage computational biology and chemistry startups. A former journalist who spent 13 years transforming MIT Technology Review into a digital-first powerhouse and three years as Senior Partner at Flagship Pioneering, Pontin brings rare storytelling and scientific fluency to deep tech investing. He co-founded Totus Medicines, a chemical biology company targeting brain cancer, and sits on boards of companies working on DNA synthesis, AI-driven drug discovery, water purification, and lab automation.